MTS Company CO., LTD.  

AiAlpa-Platform is a cancer-specialized AI-solution that provides diagnosis assistance, analyzing pathological markers(Mitosis, TSR, nuclear polymorphism, HER2, etc.) for various cancers using AI technology, and prognosis prediction results such as lymphatic metastasis, genetic testing, anticancer treatment response, etc. that pathologists cannot perform.
1) Detectable cancer types by pathological markers: breast cancer, uterine leiomyoma, bladder cancer, neuroendocrine tumors, gastrointestinal stromal tumors
- Performance(F1-Score): 90% (Each pathological markers)
2) Prognosis predictable cancer types by pathological markers: breast cancer, colon cancer, and thyroid cancer lymphatic metastasis, ovarian cancer HRD test results
- Lymphatic metastasis performance (F1-Score): 90%
- Ovarian cancer HRD prediction performance: 85%... More Info Less Info

A real-time AI diagnosis solution for cervical cancer and cervical disease that allows AI to read cervix-images taken with a mobile application and then diagnose them secondarily by a gynecologist
1) Provides immediate AI diagnosis results at the same level as the diagnosis by a gynecologist (F1-Score over 90%).
2) Links with secondary interpretation by experienced gynecologists in advanced countries, allowing women in areas with insufficient medical infrastructure to immediately receive medical services at the level of advanced countries.
3) Provides real-time disease location and diagnosis information using AR technology, making it very easy to perform accurate biopsy and treatment.... More Info Less Info